Recombinant Anti-CD3 x Anti-THY1 Bispecific Antibody (scFv-IgG) (BSSG-105)

Recombinant Anti-CD3 x Anti-THY1 Bispecific Antibody (scFv-IgG) is formed by an IgG and two scFv fragments. The scFvs from an anti-CD3 antibody variable domain are respectively connected to the N terminus of the anti-THY1 IgG heavy chains or light chains to form scFv-(H)IgG or scFv-(L)IgG. It is a type of appended IgGs and has 2+2 antigen-binding valency. This BsAb can retarget T cells to tumor cells. It is designed for the research of Leukemia therapy.

Datasheet INQUIRY

Specifications

Targets

CD3 & THY1

Type

Appended IgGs

Species Reactivity

Human

Application

FuncS; Promising therapeutic agent

Related Disease

Leukemia

Targets

Target 1

CD3

Gene ID

916

UniProt ID

P07766

Alternative Names

CD3; CD3E; CD3e molecule; Cluster of differentiation 3; CD3e molecule, epsilon (CD3-TCR complex); T3E; TCRE; IMD18; T-cell surface glycoprotein CD3 epsilon chain; CD3-epsilon; T-cell surface antigen T3/Leu-4 epsilon chain; CD3e antigen, epsilon polypeptide (TiT3 complex); T-cell antigen receptor complex, epsilon subunit of T3

Target 2

THY1

Gene ID

7070

UniProt ID

B0YJA4

Alternative Names

CD90; CDw90; THY1; Thy-1 cell surface antigen

Our products and services are for research use only, and not for use in diagnostic or therapeutic procedures.

Online Inquiry

Customer Reviews and Q&As

There are currently no customer reviews or questions for Recombinant Anti-CD3 x Anti-THY1 Bispecific Antibody (scFv-IgG) (BSSG-105). Click the button below to contact us or submit your feedback about this product.

Recombinant Anti-CD3 x Anti-THY1 Bispecific Antibody (scFv-IgG) (CAT#: BSSG-105)

Specifications

Targets

Customer Reviews and Q&As